Hsa-miR-155-5p expression in primary breast tissue may have the potential for prediction of breast cancer brain recurrence: results from the multi-institutional exploratory cohort study.

Saved in:
Bibliographic Details
Title: Hsa-miR-155-5p expression in primary breast tissue may have the potential for prediction of breast cancer brain recurrence: results from the multi-institutional exploratory cohort study.
Authors: Koyama Y; Department of Breast Surgical Oncology, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan. peach@tokyo-med.ac.jp., Muguruma M; Department of Breast Surgical Oncology, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan., Horimoto Y; Department of Breast Surgical Oncology, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.; Department of Breast Oncology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan., Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Naka-ku, Yokohama city, 232-0024, Kanagawa, Japan., Yamada A; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama city, 236-0004, Kanagawa, Japan., Yamada K; Department of Breast Surgical Oncology, Tokyo Medical University Hachioji Medical Center, 1163 Tatemachi, Hachioji city, Tokyo, 193-0998, Japan., Yamamoto S; Department of Breast Surgery, Yokohama Rosai Hospital, 3211 Kozukue-cho, Kohoku-ku, Yokohama City, 222-0036, Kanagawa, Japan., Orihara S; Department of Health Data Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku- ku, Tokyo, 160-8402, Japan., Kaise H; Department of Breast Surgical Oncology, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan., Kogure A; Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan., Yoshioka Y; Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan., Ochiya T; Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan. tochiya@tokyo-med.ac.jp., Ishikawa T; Department of Breast Surgical Oncology, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan. tishik55@gmail.com.
Source: Breast cancer research : BCR [Breast Cancer Res] 2025 Sep 29; Vol. 27 (1), pp. 169. Date of Electronic Publication: 2025 Sep 29.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1465-542X
DOI:10.1186/s13058-025-02123-5